Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Ørntoft

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Gigascience|July 4, 2015
SMAP: a streamlined methylation analysis pipeline for bisulfite sequencingShengjie Gao, Dan Zou, Likai Mao, et al.
The American Journal of Pathology|March 28, 2012
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancerNiels Fristrup, Benedicte P Ulhøi, Karin Birkenkamp-Demtröder, et al.
Cell Systems|June 12, 2017
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human ProteomesDorte B Bekker-Jensen, Christian D Kelstrup, Tanveer S Batth, et al.
International Journal of Cancer|May 18, 2010
Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancerErik D Wiklund, Jesper B Bramsen, Toby Hulf, et al.
Familial Cancer|August 22, 2009
Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patientsLise Lotte Christensen, Reetta Kariola, Mari K Korhonen, et al.
BMC Genomics|October 18, 2011
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysisKasper Thorsen, Troels Schepeler, Bodil Øster, et al.
Plos One|June 7, 2014
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumoursMoniek M Vedder, Mirari Márquez, Esther W de Bekker-Grob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
Cell Reports|May 20, 2014
Mutational context and diverse clonal development in early and late bladder cancerIver Nordentoft, Philippe Lamy, Karin Birkenkamp-Demtröder, et al.
Cell Reports|April 15, 2014
Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformationAvraham Maimon, Maxim Mogilevsky, Asaf Shilo, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Gigascience|July 4, 2015
SMAP: a streamlined methylation analysis pipeline for bisulfite sequencingShengjie Gao, Dan Zou, Likai Mao, et al.
The American Journal of Pathology|March 28, 2012
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancerNiels Fristrup, Benedicte P Ulhøi, Karin Birkenkamp-Demtröder, et al.
Cell Systems|June 12, 2017
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human ProteomesDorte B Bekker-Jensen, Christian D Kelstrup, Tanveer S Batth, et al.
International Journal of Cancer|May 18, 2010
Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancerErik D Wiklund, Jesper B Bramsen, Toby Hulf, et al.
Familial Cancer|August 22, 2009
Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patientsLise Lotte Christensen, Reetta Kariola, Mari K Korhonen, et al.
BMC Genomics|October 18, 2011
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysisKasper Thorsen, Troels Schepeler, Bodil Øster, et al.
Plos One|June 7, 2014
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumoursMoniek M Vedder, Mirari Márquez, Esther W de Bekker-Grob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
Cell Reports|May 20, 2014
Mutational context and diverse clonal development in early and late bladder cancerIver Nordentoft, Philippe Lamy, Karin Birkenkamp-Demtröder, et al.
Cell Reports|April 15, 2014
Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformationAvraham Maimon, Maxim Mogilevsky, Asaf Shilo, et al.
Pageof 8